Wt-α2 (2500 nmol/min/mg) and wt-β2 (1.2 Y122•/β2, 7600 nmol/min/mg) were expressed from pMJ1-nrdA and pTB2-nrdB, respectively, and purified as previously described.22 (link),23 (link) Y731NH2Y-α2 and Y730NH2Y-α2 were co-expressed from pTrc-nrdA-TAG731 or pTrc-nrdA-TAG730 and pAC-NH2Y, and purified as described.17 (link) All α2 proteins were pre-reduced prior to use.17 (link) E. coli thioredoxin (TR, 40 U/mg) and thioredoxin reductase (TRR, 1400 U/mg) were isolated as described.24 (link),25 (link) 2´-Azido-2´-deoxycytidine 5´-diphosphate (N3CDP) was synthesized from uridine by known procedures.26 (link),27 (link) [5-3H]-CDP was purchased from ViTrax (Placentia, CA). Nucleotide primers were purchased from Invitrogen, Pfu Ultra II polymerase from Stratagene, and restriction enzymes from New England Biolabs. Assay buffer consists of 50 mM Hepes, 1 mM EDTA, and 15 mM MgSO4, pH 7.6. Generation of pTrc-nrdB, pTrc-nrdB(TAG356), pET-nrdA(wt), pET-nrdA(TAG730), and pEVOL-NH2Y, and expression and purification of N-Strep-Y730NH2Y-α2, N-Strep-Y356NH2Y-β2, and (His)6-Y356NH2Y-β2 are described in detail in the Supporting Information (SI).